For CRC, the OS at 1, 3, and 5-year of high FoxP3+ T cells infiltration patients were higher than low FoxP3+ T cells infiltration patients (P < 0.001) and there were no differences in recurrences between high and low FoxP3+ T cells infiltration patients (P > 0.05) (Huang et al., 2014). Here, FOXP3 is linked to colorectal carcinoma.